These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35927279)

  • 1. Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings.
    Ferreira VH; Solera JT; Hu Q; Hall VG; Arbol BG; Rod Hardy W; Samson R; Marinelli T; Ierullo M; Virk AK; Kurtesi A; Mavandadnejad F; Majchrzak-Kita B; Kulasingam V; Gingras AC; Kumar D; Humar A
    Nat Commun; 2022 Aug; 13(1):4489. PubMed ID: 35927279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.
    Bormann M; Brochhagen L; Alt M; Otte M; Thümmler L; van de Sand L; Kraiselburd I; Thomas A; Gosch J; Braß P; Ciesek S; Widera M; Dolff S; Dittmer U; Witzke O; Meyer F; Lindemann M; Schönfeld A; Rohn H; Krawczyk A
    Front Immunol; 2023; 14():1150667. PubMed ID: 37520539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.
    Wang XJ; Yao L; Zhang HY; Zhu KL; Zhao J; Zhan BD; Li YK; He XJ; Huang C; Wang ZY; Jiang MD; Yang P; Yang Y; Wang GL; Wang SQ; Dai EH; Gao HX; Ma MJ
    Genome Med; 2022 Dec; 14(1):146. PubMed ID: 36581867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Variants Omicron BA.4/5 and XBB.1.5 Significantly Escape T Cell Recognition in Solid-organ Transplant Recipients Vaccinated Against the Ancestral Strain.
    Halvorson T; Ivison S; Huang Q; Ladua G; Yotis DM; Mannar D; Subramaniam S; Ferreira VH; Kumar D; Belga S; Levings MK;
    Transplantation; 2024 Apr; 108(4):e49-e62. PubMed ID: 38012843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study.
    Ferreira VH; Ierullo M; Mavandadnejad F; Kurtesi A; Hu Q; Hardy WR; Hall VG; Pinzon N; Yotis D; Gingras AC; Belga S; Shalhoub S; Hébert MJ; Humar A; Kabbani D; Kumar D
    Clin Infect Dis; 2023 Jul; 77(2):229-236. PubMed ID: 36975097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.
    Saade C; Brengel-Pesce K; Gaymard A; Trabaud MA; Destras G; Oriol G; Cheynet V; Debombourg M; Mokdad B; Billaud G; Oblette A; Créhalet H; Giannoli JM; Garrigou C; Generenaz L; Compagnon C; Boibieux A; Lina B; Morfin F; Pozzetto B; Josset L; Trouillet-Assant S; Bal A
    Emerg Microbes Infect; 2022 Dec; 11(1):2423-2432. PubMed ID: 36098494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS-CoV-2 variants including BA.1 and BA.2 in vaccinated mice.
    Zhou B; Song S; Guo H; Zhou X; Fan Q; Liu W; Cheng L; Ge X; Ju B; Zhang Z
    J Med Virol; 2022 Aug; 94(8):3992-3997. PubMed ID: 35474319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron.
    Sieber J; Mayer M; Schmidthaler K; Kopanja S; Camp JV; Popovitsch A; Dwivedi V; Hoz J; Schoof A; Weseslindtner L; Szépfalusi Z; Stiasny K; Aberle JH
    Front Immunol; 2022; 13():882456. PubMed ID: 35663948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients.
    Ferreira VH; Hu Q; Kurtesi A; Solera JT; Ierullo M; Gingras AC; Kumar D; Humar A
    Am J Transplant; 2023 Feb; 23(2):278-283. PubMed ID: 36744606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8.
    Tang Z; Yu P; Guo Q; Chen M; Lei Y; Zhou L; Mai W; Chen L; Deng M; Kong W; Niu C; Xiong X; Li W; Chen C; Lai C; Wang Q; Li B; Ji T
    Virol J; 2023 May; 20(1):106. PubMed ID: 37248496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants.
    Sonnleitner ST; Walder S; Knabl L; Poernbacher R; Tschurtschenthaler T; Hinterbichler E; Sonnleitner S; Muehlmann V; Posch W; Walder G
    Front Immunol; 2023; 14():1165769. PubMed ID: 37256137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals.
    Kang CK; Kim MG; Park SW; Kim YW; Lee CM; Choe PG; Park WB; Kim NJ; Kim M; Lee S; Kim IS; Lee CH; Shin HM; Kim HR; Oh MD
    J Med Virol; 2023 Feb; 95(2):e28558. PubMed ID: 36755360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing antibody responses in vaccinated and unvaccinated individuals infected with Omicron BA.1 variant.
    Oh SJ; O SW; Choi YJ; Kim JM; Kim D; Kim IH; Park AK; Kim HM; Rhee JE; Jang YR; Yoo CK; Kim JY; Kim EJ
    J Clin Virol; 2022 Oct; 155():105253. PubMed ID: 35988369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of CD8
    Swaminathan S; Lineburg KE; Panikkar A; Raju J; Murdolo LD; Szeto C; Crooks P; Le Texier L; Rehan S; Dewar-Oldis MJ; Barnard PJ; Ambalathingal GR; Neller MA; Short KR; Gras S; Khanna R; Smith C
    Nat Commun; 2022 Oct; 13(1):6387. PubMed ID: 36302758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
    Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
    Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.
    Emmelot ME; Vos M; Boer MC; Rots NY; de Wit J; van Els CACM; Kaaijk P
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022.
    Atari N; Kliker L; Zuckerman N; Elkader BA; Weiss-Ottolenghi Y; Mendelson E; Kreiss Y; Regev-Yochay G; Mandelboim M
    Euro Surveill; 2022 Nov; 27(44):. PubMed ID: 36330820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS-CoV-2 Omicron infection.
    Toh ZQ; Anderson J; Mazarakis N; Quah L; Nguyen J; Higgins RA; Do LAH; Ng YY; Jalali S; Neeland MR; McMinn A; Saffery R; McNab S; McVernon J; Marcato A; Burgner DP; Curtis N; Steer AC; Mulholland K; Pellicci DG; Crawford NW; Tosif S; Licciardi PV
    Clin Transl Immunology; 2024; 13(10):e70008. PubMed ID: 39364394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection.
    Belongia EA; Petrie JG; Feldstein LR; Guan L; Halfmann PJ; King JP; Neumann G; Pattinson D; Rolfes MA; McLean HQ; Kawaoka Y
    J Pediatric Infect Dis Soc; 2024 Jan; 13(1):100-104. PubMed ID: 38142128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.